共 5 条
[1]
[2]
[3]
[4]
[5]
Capecitabine (Xeloda?) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.[J].C Twelves;M Boyer;M Findlay;J Cassidy;C Weitzel;C Barker;B Osterwalder;C Jamieson;K Hieke.European Journal of Cancer.2001, 5

